Compugen (CGEN) Earnings Date & Reports

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CGEN is expected to report earnings to -7 cents per share on August 11

Q2'26

Est.

$-0.08

Q1'26

Missed

by $0.01

Q4'25

Beat

by $0.68

Q3'25

Est.

$-0.07

Q2'25

Missed

by $0.02

The last earnings report on May 18 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 118.48K shares outstanding, the current market capitalization sits at 188.77M.

View a ticker or compare two or three

Compare

CGEN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CGEN